US Stock MarketDetailed Quotes
MRK Merck & Co
- 128.420
- +2.880+2.29%
Close Jun 3 16:00 ET
- 128.640
- +0.220+0.17%
Post 19:54 ET
325.26BMarket Cap142.69P/E (TTM)
128.950High125.770Low7.70MVolume125.770Open125.540Pre Close969.68MTurnover0.31%Turnover Ratio917.29P/E (Static)2.53BShares133.10052wk High8.06P/B324.46BFloat Cap97.80652wk Low3.00Dividend TTM2.53BShs Float133.100Historical High2.34%Div YieldTTM2.53%Amplitude18.229Historical Low125.888Avg Price1Lot Size
Merck & Co Stock Forum
Sign in to post a comment
by Luzi Ann Santos
US stocks were mixed, with the $Dow Jones Industrial Average(.DJI.US$ weighed down by weak manufacturing data, while the $S&P 500 Index(.SPX.US$ and $Nasdaq Composite Index(.IXIC.US$ got a boost from gains in $NVIDIA(NVDA.US$.
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the compan...
US stocks were mixed, with the $Dow Jones Industrial Average(.DJI.US$ weighed down by weak manufacturing data, while the $S&P 500 Index(.SPX.US$ and $Nasdaq Composite Index(.IXIC.US$ got a boost from gains in $NVIDIA(NVDA.US$.
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the compan...
37
2
US stocks were mixed, with the $Dow Jones Industrial Average(.DJI.US$ weighed down by weak manufacturing data, while the $Nasdaq Composite Index(.IXIC.US$ and the $S&P 500 Index(.SPX.US$ got a boost from gains in $NVIDIA(NVDA.US$.
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the company led...
Trading in some of the stocks, including $Berkshire Hathaway-A(BRK.A.US$ were temporarily halted before 10 a.m. Monday in New York after a technical glitch that sent shares in the company led...
7
$Merck & Co(MRK.US$
⇨ $1.3B upfront payment & up to $1.7B in future milestone payments 💰
⇨ Includes Restoret™, novel late-phase candidate 👁️
» for diabetic macular edema and neovascular age-related macular degeneration
» enter pivotal study for DME in H2 2024
⇨ Deal to close in Q3 2024
⇨ $1.3B upfront payment & up to $1.7B in future milestone payments 💰
⇨ Includes Restoret™, novel late-phase candidate 👁️
» for diabetic macular edema and neovascular age-related macular degeneration
» enter pivotal study for DME in H2 2024
⇨ Deal to close in Q3 2024
7
Morning Movers
Gapping up
$Marathon Oil(MRO.US$ stock rose more than 7% following the announcement of being acquired by ConocoPhillips in a $17.1 billion all-stock deal.
$NVIDIA(NVDA.US$ stock rose 0.4%, continuing to climb after the tech giant's hefty 7% gains the previous session.
$Dick's Sporting Goods(DKS.US$ popped 7.7% after reporting an earnings and revenue beat for its fiscal first quarter and raising its full year gui...
Gapping up
$Marathon Oil(MRO.US$ stock rose more than 7% following the announcement of being acquired by ConocoPhillips in a $17.1 billion all-stock deal.
$NVIDIA(NVDA.US$ stock rose 0.4%, continuing to climb after the tech giant's hefty 7% gains the previous session.
$Dick's Sporting Goods(DKS.US$ popped 7.7% after reporting an earnings and revenue beat for its fiscal first quarter and raising its full year gui...
25
$Esperion Therapeutics(ESPR.US$ Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, have positioned it as defininte acquistion target for larger pharmaceutical companies. Esperion's drugs NEXLIZET and NEXLETOL now have primary prevention labels, NEXLIZET will soon become the drug of choice over a PCSK9 inhibitor says Texas based HeartPlace leading Cardio...
12
Interesting both for the (1) shift in the macro-trend to M&A (vs. Licensing) and (2) change in top spenders
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
10
1
See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb(BMY.US$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US$ : Arexvy
$Genfit(GNFT.US$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US$ : Augtyro...
$Bristol-Myers Squibb(BMY.US$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US$ : Arexvy
$Genfit(GNFT.US$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US$ : Augtyro...
7
1
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
9
2
Top 10 drug companies raked in NEARLY TRIPLE the revenue in 2023 ($491B) vs 2013 ($165B) 2013 vs. 2023.
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
$AbbVie(ABBV.US$ +189%
$Bristol-Myers Squibb(BMY.US$ +175%
$Johnson & Johnson(JNJ.US$ +95%
$AstraZeneca(AZN.US$ +78%
$NVM +45%
$Merck & Co(MRK.US$ +37%
$ROCHE HOLDING AG(RHHBY.US$ +27%
$Pfizer(PFE.US$ +13%
$GlaxoSmithKline(GSK.US$ +13%
----- $SPDR S&P 500 ETF(SPY.US$ +12% -----
$Sanofi(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
6
1
Fed has kept interest rate unchanged at 5.5%. That’s 6th straight meeting of pause.
Powell said a rate hike is unlikely. But he also admitted that inflation is lacking progress towards their 2%.
His speech sounded neutral to me.
The market reacted positively by spiking up, but the pop quickly faded, and we went back to the level before Powell’s speech.
$ARK 21Shares Bitcoin ETF(ARKB.US$ $Super Micro Computer(SMCI.US$ $Roku Inc(ROKU.US$ $Arm Holdings(ARM.US$ $Johnson & Johnson(JNJ.US$ $Zoom Video Communications(ZM.US$ $Walmart(WMT.US$ $Target(TGT.US$ $Nike(NKE.US$ $Coca-Cola(KO.US$ $PepsiCo(PEP.US$ $XPeng(XPEV.US$ $Merck & Co(MRK.US$ $Baidu(BIDU.US$ $AMC Entertainment(AMC.US$ $GameStop(GME.US$
Powell said a rate hike is unlikely. But he also admitted that inflation is lacking progress towards their 2%.
His speech sounded neutral to me.
The market reacted positively by spiking up, but the pop quickly faded, and we went back to the level before Powell’s speech.
$ARK 21Shares Bitcoin ETF(ARKB.US$ $Super Micro Computer(SMCI.US$ $Roku Inc(ROKU.US$ $Arm Holdings(ARM.US$ $Johnson & Johnson(JNJ.US$ $Zoom Video Communications(ZM.US$ $Walmart(WMT.US$ $Target(TGT.US$ $Nike(NKE.US$ $Coca-Cola(KO.US$ $PepsiCo(PEP.US$ $XPeng(XPEV.US$ $Merck & Co(MRK.US$ $Baidu(BIDU.US$ $AMC Entertainment(AMC.US$ $GameStop(GME.US$
From YouTube
2
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
72549611 :
102188459 : Tq